The neurons of the locus ceruleus are responsible for most of the noradrene
rgic innervation in the brain and nicotine potentiates noradrenaline releas
e from their terminals. Here we investigated the diversity and subcellular
distribution of nicotinic acetylcholine receptors (nAChRs) in the locus cer
uleus both somatically, by combining single-cell reverse transcription-PCR
with electrophysiological characterization, and at the level of nerve termi
nals, by conducting noradrenaline efflux experiments. The proportion of neu
rons in the locus ceruleus expressing the nicotinic subunit mRNAs varied fr
om 100% (beta 2) to 3% (alpha 2). Yet, two populations of neurons could be
distinguished on the basis of the pattern of expression of nAChR mRNAs and
eletrophysiological properties. One population (type A) of small cells syst
ematically expressed alpha 3 and beta 4 mRNAs (and often alpha 6, beta 3, a
lpha 5, alpha 4), and nicotinic agonists elicited large currents with a pot
ency order of cytisine > nicotine. Another population (type 8) of cells wit
h large soma did not contain alpha 3 and beta 4 mRNAs but, systematically,
alpha 6 and beta 3 (and often alpha 4) and responded to nicotinic agonists
in the order of nicotine > cytisine. The nicotinic modulation of noradrenal
ine release in the hippocampus displayed an order of potency nicotine > cyt
isine, suggesting that noradrenergic terminals in the hippocampus originate
largely from type 8 cells of the locus ceruleus. Accordingly, immunocytoch
emical labeling showed that beta 3 is present in hippocampal terminals. The
alpha 6 beta 3 beta 2(alpha 4) heterooligomer thus behaves as the main nic
otinic regulator of the ceruleo-hippocampal pathway.